What does Pulmonx do?
We are a commercial-stage medical technology company that provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). Our solution, which is comprised of the Zephyr® Endobronchial Valve (Zephyr Valve), the Chartis® Pulmonary Assessment System (Chartis System) and the StratX® Lung Analysis Platform (StratX Platform), is designed to treat severe emphysema patients who, despite medical management, are still profoundly symptomatic and either do not want or are ineligible for surgical approaches.
Where is Pulmonx’s corporate headquarters?
Our principal executive offices are located at 700 Chesapeake Drive, Redwood City, California, and our telephone number is (650) 364-0400.
Where and when was Pulmonx incorporated?
We were initially incorporated under the laws of the State of California in December 1995 under the name Pulmonx. We reincorporated under the laws of the State of Delaware in December 2013 under the name Pulmonx Corporation.
On what stock exchange are Pulmonx shares traded, and what is the ticker symbol?
Our ticker is LUNG and it is traded on the Nasdaq Global Select Market.
Where can I find all of Pulmonx’s SEC filings? Where can I download and view quarterly and annual reports?
Quarterly and annual reports, as well as other SEC filings, can be accessed on the
SEC Filings portion of our Investor Relations website or directly from the SEC at
www.sec.gov.
When does Pulmonx’s fiscal year end?
Our fiscal year end is December 31.
Who are the Company's independent registered public accountants?
Our independent registered public accountants are BDO, USA, LLP.
Who is the Company’s transfer agent?
Equiniti Trust Company, LLC (“EQ”)
48 Wall Street, Floor 23
New York, NY 10005
Who are the members of Pulmonx’s Board of Directors?
You can view our Board of Directors by visiting the
Board Members section of our website.
Who are the members of the Pulmonx management team?
You can view our management team by visiting the
Management section of our website.
When is your next earnings release?
We will issue a national press release that includes the date of our quarterly earnings call. When the release is issued, it will be posted on the
Events section of our website along with the details for a conference and/or webcast to discuss the results.
How do I contact Investor Relations with a question or request?
Who to contact with questions about Pulmonx shares?
If your shares are held in street name (by your broker), you must notify the securities firm holding your stock. If you hold stock certificates in your name, you may reach our transfer agent at the address or phone numbers below:
Equiniti Trust Company, LLC (“EQ”)
48 Wall Street, Floor 23
New York, NY 10005
(800) 937-5449 for U.S. and Canada callers
(718) 921-8124 for International callers
Can I replace a lost certificate?
If you hold stock certificates in your name, please contact our transfer agent regarding the replacement of lost certificates at the address or phone numbers at the address or phone numbers below:
Equiniti Trust Company, LLC (“EQ”)
48 Wall Street, Floor 23
New York, NY 10005
(800) 937-5449 for U.S. and Canada callers
(718) 921-8124 for International callers
